2023-08-03 06:12:42 ET
- Pediatrix Medical Group press release ( NYSE: MD ): Q2 Non-GAAP EPS of $0.39 misses by $0.01 .
- Revenue of $500.6M (+3.0% Y/Y) beats by $4.75M .
- Pediatrix’s overall same-unit revenue increased by 3.2 percent, slightly offset by the impact of net non-same unit activity.
- Same-unit revenue from net reimbursement-related factors increased by 2.6 percent for the 2023 second quarter as compared to the prior-year period.
- Pediatrix anticipates that its 2023 Adjusted EBITDA will be in a range of $235 million to $245 million.
For further details see:
Pediatrix Medical Group Non-GAAP EPS of $0.39 misses by $0.01, revenue of $500.6M beats by $4.75M